You are here

Article Text

Article menu

Download PDFPDF

Complementary medicine
Protocol
Immediate acupuncture with GB34 for biliary colic: protocol for a randomised controlled neuroimaging trial
  1. Ning Sun1,
  2. Dong-Mei He2,
  3. Xiangyin Ye1,
  4. Lei Bin2,
  5. Yuanfang Zhou1,
  6. Xiaodong Deng1,
  7. Yuzhu Qu1,
  8. Zhengjie Li1,
  9. Shirui Cheng1,
  10. Shuai Shao2,
  11. Feng-Juan Zhao3,
  12. Tie-Huan Zhang2,
  13. Jing Cai4,
  14. Ruirui Sun1,
  15. Fan-rong Liang1
  1. 1Acupuncture and Tuina School/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
  2. 2Emergency Department, The First People’s Hospital of Longquanyi District, Chengdu, Sichuan, China
  3. 3Science and Education Department, The First People’s Hospital of Longquanyi District, Chengdu, China
  4. 4Oncology-Blood Department, The First People’s Hospital of Longquanyi District, Chengdu, China
  1. Correspondence to Dr Fan-rong Liang; acuresearch{at}126.com

Abstract

Introduction As the main manifestation of gallstone disease, biliary colic (BC) is an episodic attack that brings patients severe pain in the right upper abdominal quadrant. Although acupuncture has been documented with significance to lead to pain relief, the immediate analgesia of acupuncture for BC still needs to be verified, and the underlying mechanism has yet to be covered. Therefore, this trial aims first to verify the immediate pain-alleviation characteristic of acupuncture for BC, then to explore its influence on the peripheral sensitised acupoint and central brain activity.

Methods and analysis This is a randomised controlled, paralleled clinical trial, with patients and outcome assessors blinded. Seventy-two patients with gallbladder stone disease presenting with BC will be randomised into a verum acupuncture group and the sham acupuncture group. Both groups will receive one session of immediate acupuncture treatment. Improvements in patients’ BC will be evaluated by the Numeric Rating Scale, and the pain threshold of acupoints will also be detected before and after treatment. During treatment, brain neural activity will be monitored with functional near-infrared spectroscopy (fNIRS), and the needle sensation will be rated. Clinical and fNIRS data will be analysed, respectively, to validate the acupuncture effect, and correlation analysis will be conducted to investigate the relationship between pain relief and peripheral–cerebral functional changes.

Ethics and dissemination This trial has been approved by the institutional review boards and ethics committees of the First Teaching Hospital of Chengdu University of Traditional Chinese Medicine, with the ethical approval identifier 2019 KL-029, and the institutional review boards and ethics committees of the First People’s Hospital of Longquanyi District, with the ethical approval identifier AF-KY-2020071. The results of this trial will be disseminated through peer-reviewed publications and conference abstracts or posters.

Trial registration number CTR2000034432.

  • complementary medicine
  • pain management
  • hepatobiliary disease
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/bmjopen-2021-050413

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Strengths and limitations of this study

    • This randomised controlled trial will first use functional near-infrared spectroscopy (fNIRS) to investigate cerebral changes during acupuncture for biliary colic (BC).

    • Combining observations of both peripheral acupoint sensitisation and cerebral activity influenced by acupuncture will contribute to exploring the partial mechanism of acupuncture for BC alleviation.

    • Both objective and subjective outcomes will be used to evaluate the effects of acupuncture treatment on BC.

    • Owing to a limited number of fNIRS measurement channels, we will restrict our analysis to the dorsolateral prefrontal cortex and primary somatosensory cortex of the patients.

    • The cumulative effect of acupuncture for patients with gallstone disease with recurrent pain and accompanying discomforts, such as nausea and vomiting, will be further studied in the future.

    Introduction

    Gallstone disease is one of the most common gastrointestinal and biliary system disorders.1 As the main manifestation of gallstone disease, biliary colic (BC) is severe pain in the right upper abdominal quadrant that attacks patients for at least 20–30 min.2–4 In the developed world, 10%–15% of adults have gallstones, and BC occurs in 1%–4% of those with gallstones each year.5 It is reported that the cumulative probability of developing BC in initially asymptomatic people is approximately 11.9%±3.0% at 2 years and 25.8%±4.6% at 10 years.6 Moreover, BC can significantly impair sleep, mood and quality of life and cause major economic and social burdens.7 8

    Compelling evidence indicates that non-steroidal anti-inflammatory drugs (NSAIDs) are effective in relieving BC.9 However, long-term use of these medications has been considered to carry side effects.10–12 As one of the complementary therapies, acupuncture is thought to be effective for alleviating acute pain with rare side effects.13–15 For many diseases with visceral pain, acupuncture has been proven to be effective. For instance, Zhao et al demonstrated that acupuncture is beneficial for the alleviation of angina as an adjunctive therapy.16 More recently, Pei et al reported that acupuncture may be more effective than conventional drugs for abdominal pain relief of patients with irritable bowel syndrome.17 However, although several studies have shown that acupuncture can relieve BC,18–21 the immediate analgesia of acupuncture for BC still needs to be verified.

    In the peripheral system, acupuncture can inhibit the contractions of Oddi’s sphincter, bidirectionally regulate the gallbladder pressure, promote the secretion of hepatic bile and so on.22–25 However, the central mechanism underlying acupuncture for BC relief still needs further investigation. Brain activity is closely correlated with the regulation of visceral function, and central integration is the key to achieving good regulation of visceral function by acupuncture.26 27 At the same time, the state of acupoints and the function of the viscera are considered to be dynamic, having a two-way relationship with one another.28

    The rapid development of neuroimaging technologies, such as functional MRI (fMRI), positron emission tomography, electroencephalography, functional near-infrared spectroscopy (fNIRS), has provided possibilities for neural activity research. Among them, fMRI is the most commonly used technique. However, in the current study, it is difficult for patients with BC to remain confined during MRI, with their body and head motions strictly controlled.29 Compared with fMRI, fNIRS is similarly successful in detecting brain functional activities by measuring concentration changes of oxygenated and deoxygenated haemoglobin (△HbO and △HbR), but it is more flexible without these limitations and has a better temporal resolution.30 In addition, fNIRS is also a non-invasive method and has better spatial resolution than electroencephalography.31 This neuroimaging technique has been used to assess cortical activity in diverse diseases, such as pain disease,32 attention-deficit/hyperactivity disorder,33 cerebral palsy34 and cognitive impairment.35

    The current study aims to (1) retestify the immediate analgesic effect of acupuncture by comparing it to sham acupuncture; (2) investigate the potential central mechanism of this analgesic effect by using fNIRS to monitor patients’ brain activity during acupuncture procedure; (3) explore the underlying peripheral–cerebral influence by correlating the clinical improvement and pain threshold of acupoint with cerebral neural activity.

    Methods

    Study design

    This is a 1:1 randomised placebo-controlled trial with two parallel groups. This trial will be reported in accordance with the Standard Protocol Items: Recommendations for Intervention Trials guidelines36 and will follow the principles of the Consolidated Standards of Reporting Trials and Standards for Reporting Interventions in Clinical Trials of Acupuncture statements.37 38

    Seventy-two participants will be recruited in this study, with 36 participants allotted to each group. All participants will receive one session of acupuncture treatment. As shown in figures 1 and 2, clinical measurements and behavioural data of all participants will be assessed before and after their acupuncture treatment. Each patient’s cerebral activity will be synchronously detected by fNIRS during acupuncture treatment.

    Figure 1
    Figure 1

    Flow chart of the study design. BC, biliary colic; fNIRS, functional near-infrared spectroscopy.

    Figure 2
    Figure 2

    Standard protocol items. fNIRS, functional near-infrared spectroscopy; NRS, Numeric Rating Scale; SAS, Zung Self-rating Anxiety Scale; SDS, Zung Self-rating Depression Scale; SF-12, 12-item Short-form Health Survey.

    Patient population and recruitment strategy

    Participants will be screened and recruited from the emergency department and the general surgery department of the First Teaching Hospital of Chengdu University of Traditional Chinese Medicine (TCM) (Chengdu, China) and the First People’s Hospital of Longquanyi District (Chengdu, China) from July 2020 to December 2021. Trained researchers will conduct screening of participants. All patients will be fully informed of the experimental procedures, and informed consent will be obtained from all participants prior to their enrolment. Participants will be informed that they are free to withdraw from the study without penalty at any time. For this study, the diagnosis of gallbladder stone disease (GSD) follows the criteria of the European Association for the Study of the Liver.39 Patients with GSD who manifest BC and match the inclusion criteria will be included.

    Inclusion criteria

    The study inclusion criteria are as follows:

    1. Age between 18 and 60 years.

    2. Right handed.

    3. Mild tenderness in the right upper abdomen, with Murphy’s sign (−).

    4. No history of having taken any NSAIDs within 2 weeks before enrolment.

    5. Signed the informed consent form.

    Exclusion criteria

    The study exclusion criteria are as follows:

    1. Calculus in the bile duct.

    2. Acute cholecystitis, acute suppurative, gangrenous, incarcerated cholecystitis, or perforation of the gallbladder with diffuse peritonitis.

    3. Serious complications or primary diseases affecting the cerebral, cardiovascular, liver, kidney, endocrine or haematopoietic system.

    4. Severe digestive system diseases, such as peptic ulcer, upper gastrointestinal haemorrhage, gastric tumour, Crohn’s disease or irritable bowel syndrome.

    5. Other causes of upper abdominal pain, such as gastritis, enteritis, pancreatitis or peritonitis.

    6. White cell count of greater than 15×109/L with a systemic inflammatory response.

    7. Mental disorders, such as serious anxiety and/or depression (at least 70 points on the Zung Self-Rating Anxiety Scale or at least 72 points on the Zung Self-rating Depression Scale).40 41

    8. Taking other medications, such as chronic analgesic drugs.

    9. Pregnancy or lactating women.

    10. History of participation in any other clinical trial in the past 3 months.

    11. History of receiving any acupuncture treatment in the past month.

    Sample size considerations

    According to a previous study, a Visual Analog Scale score of acute pain decreased by 2.4 points after acupuncture and by 0.7 points after sham acupuncture.42 In this study, we anticipate a reduction in the Numeric Rating Scale (NRS) score by 2.4 points after acupuncture and a reduction by one point after sham acupuncture. With α=0.05, 1 − β=0.8 and a SD of 2, 33 participants would be required per group. Estimating a dropout rate of 10%, we planned to enrol 72 participants, with 36 allotted to each group. Based on previous neuroimaging studies, the optimal sample size for a study is between 16 and 32 subjects.43 Considering the dropout rate and loss of data due to head motion, 25 participants per group will undergo fNIRS imaging in this trial.

    Randomisation and blinding

    A random sequence will be generated by a third-party professional statistician using the SAS V.9.2 software (SAS Institute). The randomisation list will be placed in sealed opaque envelopes and opened by a non-involved investigator in consecutive order. A total of 72 participants with GSD will be randomised in a ratio of 1:1 to the acupuncture with Yanglingquan (GB34) group or the sham acupuncture group, with 36 patients in each group. It is difficult to blind the acupuncturists to treatment allocation, but the patients, outcome assessors, and statisticians will be blinded to treatment allocation. Participants in different groups will be separated into cubicles to limit communication, and the same type of Park device will be used for ensuring the blinding of participants. Moreover, participants will be told that there are two different types of acupuncture provided in this study; terms such as “placebo” or “sham” will not be used. Therefore, sham acupuncture aims to control not only the superficial and cutaneous somatosensory effects around the GB34 acupoint but also the cognitive processing induced by the participants’ expectations of acupuncture.44

    Patient and public involvement

    Patients in this trial will not be involved in the design, recruitment or conduct of the study. The patients will be able to view the study results via social media.

    Interventions

    Participants will receive one session of acupuncture either on the right GB34 or on the sham acupoint, which will be conducted by trained, licensed acupuncturists with at least 3 years of clinical experience in acupuncture. The sham acupoint is on the lateral side of the tibia, 1 to 2 cm lateral to ST36 (Zusanli)45 (figure 3). The location of GB34 is on the lateral side of the lower leg, in the depression anterior and inferior to the head of the fibula. The location of ST36 is four fingers’ breadth below the lower margin of the patella and one finger’s breadth laterally from the anterior crest of the tibia.

    Figure 3
    Figure 3

    Location of acupoint or non-acupoint in the trial.

    Both groups will undergo the same acupuncture procedure and manipulation. For the acupuncture procedure, four different acupuncture manipulations will be used. Specifically, the first task is needle insertion (NI), followed by an initial twirl to activate the acupoint. The second task is the first run of needle twirl, which is repeated four times (T1, T2, T3, and T4) to keep the acupoint activated. The duration of the second task is 140 s, including four twirls (4×20 s) and three rest times (3×20 s). Then, the needle remains for 5 min to maintain deqi sensation. The third task is the second run of needle twirl, which is repeated four times (T5, T6, T7, and T8) to strengthen the deqi sensation. The third task is the same length of time as the second task (140 s). Finally, the last task is needle removal (NR). The acupuncture procedure will last a total of 10 min and 30 s (figure 4).

    Figure 4
    Figure 4

    Experimental paradigm.

    For acupuncture manipulation, disposable sterile filiform needles (0.25×40 mm; Huatuo, Suzhou, China) with a Park device will be used in the acupuncture group to be perpendicularly inserted into the point at a depth of 21–26 mm after skin disinfection using alcohol (figure 5). During each needle twirl, the needle will be bidirectionally twisted within 90° to 180°, lifted, and thrust at an even amplitude between 3 and 5 mm for 1 to 1.5 Hz (60–90 times/min) to induce and maintain the deqi sensation (including soreness, numbness, distention, and heaviness).46 47

    Figure 5
    Figure 5

    Verum acupuncture and sham acupuncture.

    The sham acupuncture group will receive non-insertive acupuncture using the Park sham needle supported by the Park device (figure 5).48 The acupuncturist will be instructed to lightly position the sham needle against the surface of the skin to minimise any physiological effect.49

    Acupuncture will be discontinued and patients will be treated immediately when they experience severe discomforts, such as pain, bleeding or fainting. After finishing the acupuncture treatment, participants will be able to receive medication if they still have BC, and the type and dosage of medication used will also be recorded in the case report form (CRF).

    Outcome measures

    Clinical outcome assessments

    The primary outcome is the mean difference in the change in pain intensity between before and after an intervention. To measure patients’ self-reported pain intensity before and after acupuncture,50 51 the NRS will be used. The NRS is a horizontal line with 10 segments labelled from 0 (‘no pain at all’) to 10 (‘the worst pain imaginable’).

    Other clinical data, including demographic information, participants’ quality of life, and psychosocial state at the baseline, will also be recorded. The standard protocol items of the study are exhibited in figure 2. The 12-item Short-form Health Survey,52 Zung Self-rating Anxiety Scale40 and Zung Self-rating Depression Scale41 will be used to evaluate participants’ quality of life and psychosocial state at baseline.

    To assess deqi during acupuncture, a needle-sensation evaluation form will be deployed to two groups at four time points: after NI, after T4, after T8, and after NR. This form is based on the Chinese version of the modified Massachusetts General Hospital Acupuncture Sensation Scale (C-MASS), and its validity and reliability have been previously examined.53 54 Needle sensation is an indispensable part of acupuncture treatment.55 The needle-sensation evaluation form includes deqi features (soreness, distention, numbness, heaviness, dull pain, and so on) and a rating of deqi intensity. Patients will be asked to describe the intensity of deqi with a 10-point Visual Analog Scale labelled from 0 (‘none’) to 10 (‘unbearable’).

    Pain threshold measurements of the acupoint

    Based on the TCM theory, a disorder of the viscera inside the body must have some manifestation outside, and the acupoint can show a person’s response to disease externally. To explore the activation of the (sham) acupoint and its association with pain relief among patients with BC after acupuncture, the mechanical and pressure pain thresholds (PPTs) will be measured.

    The mechanical pain threshold will be measured using the electronic Von Frey esthesiometer (model 2390; IITC Life Science, Woodland Hills, California, USA). It has been found that this device can detect hyperalgesia and changes in sensory nerve function.56–58 At the point, a progressive pressure will be applied at a rate of 10 g/s. The average mechanical pain threshold for the GB34 point/sham acupoint will be calculated.

    The PPT will be measured using the FDIX force gauge (Force One FDIX; Wagner Instruments, Greenwich, Connecticut, USA). PPT is widely used in clinical practice as a semiobjective method with which to quantify localised pain.59 60 At the point, a progressive pressure will be applied at a rate of 100 gf/s. The average PPT for the GB34 point/sham acupoint will be calculated.

    If there is a difference of more than 15 g/500 gf (separately for the mechanical pain threshold and PPT) between the two measurements performed at one acupoint, a third group of measurements will be taken. The two devices described have been used in our previous study.61

    fNIRS imaging and data collection fNIRS—a method of optical neuroimaging that characterises haemodynamic changes at the brain’s surface in a priori–identified regions of the brain—will be used for the measurement of cortical neural activation of patients’ brains. An fNIRS system (OMM-3000; Shimadzu, Kyoto, Japan) that has continuous-wave laser diodes with 780, 805 and 830 nm wavelengths will be used in this experiment.62 The optodes will be positioned over the international 10–20 system for electroencephalography electrode placement by using individually sized caps selected according to head circumference. About 10 locations will be spatially adjusted across all cap sizes to maintain consistent coverage of our regions of interest.63 64 For accurate fixation, the optodes will be mounted on the holder in the NIRS cap, and the distance between pairs of light sources and detector optodes will be set to 2.5–3 cm.65

    In the present study, eight emitters and eight detectors will be used to thoroughly investigate the dorsolateral prefrontal cortex (DLPFC) and primary somatosensory cortex of the human brain. The emitters will be positioned by considering Fpz and Cz as reference points. A total of 20 channels will be configured using emitter–detector combinations.

    Safety and monitoring

    To provide an overview of their health status, each participant in this study will undergo a series of health evaluations, including an abdominal ultrasound, blood biochemical test and ECG examination. Any acupuncture treatment-related adverse events, such as haematoma, subcutaneous haemorrhage, serious pain, local infection, broken needle and fatigue, will be processed immediately and recorded in detail in the CRF. Adverse events of the acupuncture group and sham acupuncture group will be compared.

    Quality control and data collection and management

    All researchers will receive a series of training before the start of this study, to ensure that they fully understand the study protocol and standard procedures. CRFs labelled by unique numeric identifiers will be used to collect relevant data, adverse events and safety assessments for patients. Only outcome assessors have access to CRFs and will perform the double data entry. The Evidence-based Medicine Center of the Chengdu University of TCM will be in charge of supervising the study and monitoring data every 3 months.

    Statistical analysis

    Clinical data analysis

    Clinical data will be statistically analysed using the Statistical Package for the Social Sciences V.22.0 software program (IBM Corporation), with a significance level of 0.05, and all hypothesis tests will be two tailed. Skewed data distribution will be normalised. Means, SD and 95% CIs will be computed to describe continuous variables.

    Baseline demographic characteristics, NRS scores and pain threshold values between the two groups will be analysed with the χ2 test or Fisher’s exact test for categorical measures and with the t-test or Wilcoxon rank-sum test for continuous measures. The needle sensation will be compared between the two groups at four time points by using a 2×4 repeated-measures analysis of covariance approach.

    fNIRS data analysis

    Data will be analysed in MATLAB V.8.6 (Mathworks, Natick, Massachusetts, USA). First, a wavelet motion-correction procedure will be used for motion artefacts with all-optical density data.64 Next, the optical density data will be converted to HbO and HbR values using the modified Beer-Lambert law.66 Data from individual channels will be visually inspected for excessive noise. Channels with excessive noise will be excluded from subsequent analyses. In addition, we will employ a wavelet-based method to remove global noise, which is used as a powerful mathematical tool in fNIRS data preprocessing.67–69 To obtain an average response for each of the 20 channels in each participant, the haemodynamic response function will be estimated by a general linear model approach using ordinary least squares.

    Correlation analyses will be used to investigate associations among clinical outcomes, pain threshold values of the acupoint and fNIRS data. Differences in correlations between two groups will be further examined by group-level analysis.

    Discussion

    This is a randomised controlled, paralleled clinical trial seeking to explore the immediate pain alleviation of acupuncture for BC and its influence on the peripheral sensitised acupoint and central brain activity.

    According to the TCM theory, GB34 is the Lower He-sea point of the gallbladder and is considered specifically connected to the gallbladder. As one of the most common acupoints used for GSD treatment, acupuncture with GB34 is considered effective for the treatment of gallstone disease.19 20 24 Some clinical studies have reported that sham acupuncture interventions, such as needle insertion at a sham acupoint, are not entirely ineffective due to their associations with moderately large, non-specific effects.70 71 Thus, in clinical trials, sham acupuncture involving penetrating needling is not recommended.72 73 To better verify the effectiveness of manual acupuncture with GB34, a non-inserted needle at a non-acupoint is chosen as the sham control technique to minimise physiological effects in the sham group. Thus, a non-acupoint on the lateral side of the lower leg, which is almost at the same level as the GB34 acupoint, will be chosen in the sham group to blind participants in this study. However, a recent review indicates that sham acupuncture and verum acupuncture have almost identical efficacy when the dermatomes that are stimulated highly overlap.74 The present study may help to test these authors’ arguments. Because the pain of patients with BC is so severe that they can tolerate fNIRS imaging for only a short time, acupuncture with a short-time needle retention time (10 min and 30 s) will be chosen after the pilot study.

    Recent Chinese research has found that, when the body is in a state of disease, disease-related acupoints can be sensitised.75–77 Pain sensitivity is one of the most important sensitivity manifestations at sensitised acupoints, and its degree may be correlated with disease condition.57 58 Considering the importance of acupoint sensitisation for the acupuncture effect, we will measure the pain threshold of GB34 and observe the efficacy of acupuncture at GB34 for the treatment of BC. In addition to NRS and C-MASS, which offer subjective-state measurements, we also evaluated the impact of acupuncture treatment on objective outcomes using pain threshold values and the fNIRS data. Meanwhile, correlations will be analysed to investigate associations among clinical outcomes, pain threshold values of the acupoint, and fNIRS data.

    fNIRS is suitable for all possible participant populations, from newborns to the elderly, and in a variety of experimental settings both inside and outside the laboratory.78 79 Some diseases with acute pain, such as BC, are difficult to investigate in tightly restrained environments, such as an fMRI system. The process of fNIRS recording is silent, relatively comfortable and does not impose physical constraints on the participant,80 which means it is a good choice of imaging modality for many studies of patients with acute pain. Moreover, a major reason for choosing fNIRS is that the usage of metal objects is applicable. For acupuncture studies, because acupuncture needles are magnetic metals, it is impossible to implement treatment and fMRI imaging at the same time. Therefore, using fNIRS, the synchronisation of acupuncture treatment and brain-image collection can be realised.

    According to previous literature, acupuncture stimulation modulates the cortical activities of the somatomotor area in humans.81 82 Moreover, acupuncture at GB34 can activate the somatomotor area and DLPFC in healthy subjects in our pilot trial. The DLPFC has displayed a critical role in pain modulation.83 In particular, DLPFC is a key node of several brain networks and may be a key node of networks implicated in nociceptive processing and control.84 A study reported that left DLPFC activity is negatively correlated with pain unpleasantness.85 Freund et al found that subjects given instructions to suppress pain show increased activation of the bilateral DLPFC during prolonged acute pain stimulation.86 There is converging evidence that the DLPFC has a role in cognitive components of the pain experience. Therefore, the somatomotor area and DLPFC will be chosen as brain regions of interest for this study.

    In this trial, the following measures will be taken to strengthen quality control: (1) this study restricts participants to ages between 18 and 60 years and to being right handed, avoiding the impact of age and handedness on brain function and structure; (2) to get stable statistic power, 36 patients will be included in each group for clinical evaluation and 25 patients in each group for the central mechanism study; (3) all researchers will be uniformly trained to understand the design and process of the trial, and the acupuncture treatment will be performed by two licensed acupuncturists, who have received special and standardised training before the trial; (4) one technician will perform all scans in the same fNIRS machine according to the operation standard and the design of the study in the fixed condition, and, before being scanned, the mental state of each participant will be evaluated using the Zung Self-rating Anxiety Scale and Zung Self-rating Depression Scale.

    In summary, this study is planned as a randomised controlled, paralleled clinical trial to evaluate the efficacy and central mechanism of acupuncture treatment on BC compared with sham acupuncture. To our knowledge, it is the first functional brain imaging study focusing on exploring the immediate pain alleviation of acupuncture for BC and its influence on the peripheral sensitised acupoint and central brain activity. The findings may provide evidence of the clinical benefits and mechanisms of acupuncture for patients with BC.

    Ethics statements

    Patient consent for publication

    Ethics approval

    This study was approved by Sichuan Regional Ethics Review Committee of Traditional Chinese Medicine (2019KL-029); Medical Ethics Committee of Hospital Affiliated to Chengdu University of Traditional Chinese Medicine (AF-KY-2020071). Participants gave informed consent to participate in the study before taking part.

    References

    1. ↵
      1. Johnston MJ,
      2. Fitzgerald JEF,
      3. Bhangu A, et al
      . Outpatient management of biliary colic: a prospective observational study of prescribing habits and analgesia effectiveness. Int J Surg 2014;12:169–76.doi:10.1016/j.ijsu.2013.12.003pmid:http://www.ncbi.nlm.nih.gov/pubmed/24342080
      OpenUrlPubMed
    2. ↵
      The epidemiology of gallstone disease in Rome, Italy. Part II. factors associated with the disease. The Rome group for epidemiology and prevention of cholelithiasis (GREPCO). Hepatology 1988;8:907–13.pmid:http://www.ncbi.nlm.nih.gov/pubmed/3391520
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      1. Baiu I,
      2. Hawn MT
      . Gallstones and biliary colic. JAMA 2018;320:1612.doi:10.1001/jama.2018.11868pmid:http://www.ncbi.nlm.nih.gov/pubmed/30326127
      OpenUrlPubMed
    4. ↵
      1. Portincasa P,
      2. Moschetta A,
      3. Petruzzelli M, et al
      . Gallstone disease: symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol 2006;20:1017–29.doi:10.1016/j.bpg.2006.05.005pmid:http://www.ncbi.nlm.nih.gov/pubmed/17127185
      OpenUrlCrossRefPubMed
    5. ↵
      1. Ansaloni L,
      2. Pisano M,
      3. Coccolini F
      . WSES guidelines on acute calculous cholecystitis. World J Emerg Surg 2016;2016:25.
      OpenUrl
    6. ↵
      1. Attili AF,
      2. De Santis A,
      3. Capri R, et al
      . The natural history of gallstones: the GREPCO experience. The GREPCO group. Hepatology 1995;21:656–60.doi:10.1002/hep.1840210309pmid:http://www.ncbi.nlm.nih.gov/pubmed/7875663
      OpenUrlCrossRefPubMed
    7. ↵
      1. Everhart JE,
      2. Ruhl CE
      . Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 2009;136:1134–44.doi:10.1053/j.gastro.2009.02.038pmid:http://www.ncbi.nlm.nih.gov/pubmed/19245868
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      1. Shaffer EA
      . Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132–40.doi:10.1007/s11894-005-0051-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/15802102
      OpenUrlCrossRefPubMed
    9. ↵
      1. Fraquelli M,
      2. Casazza G,
      3. Conte D, et al
      . Non-Steroid anti-inflammatory drugs for biliary colic. Cochrane Database Syst Rev 2016;9:CD006390.doi:10.1002/14651858.CD006390.pub2pmid:http://www.ncbi.nlm.nih.gov/pubmed/27610712
      OpenUrlCrossRefPubMed
    10. ↵
      1. García-Rayado G,
      2. Navarro M,
      3. Lanas A
      . Nsaid induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Rev Clin Pharmacol 2018;11:1031–43.doi:10.1080/17512433.2018.1516143pmid:http://www.ncbi.nlm.nih.gov/pubmed/30139288
      OpenUrlPubMed
    11. ↵
      1. Aminoshariae A,
      2. Kulild JC,
      3. Donaldson M
      . Short-Term use of nonsteroidal anti-inflammatory drugs and adverse effects: an updated systematic review. J Am Dent Assoc 2016;147:98–110.doi:10.1016/j.adaj.2015.07.020pmid:http://www.ncbi.nlm.nih.gov/pubmed/26562732
      OpenUrlCrossRefPubMed
    12. ↵
      1. Long B,
      2. April MD
      . Are nonsteroidal anti-inflammatory drugs efficacious in relieving biliary colic pain? Ann Emerg Med 2017;70:822–4.doi:10.1016/j.annemergmed.2017.03.012pmid:http://www.ncbi.nlm.nih.gov/pubmed/28460865
      OpenUrlPubMed
    13. ↵
      1. Beltaief K,
      2. Grissa MH,
      3. Msolli MA, et al
      . Acupuncture versus titrated morphine in acute renal colic: a randomized controlled trial. J Pain Res 2018;11:335–41.doi:10.2147/JPR.S136299pmid:http://www.ncbi.nlm.nih.gov/pubmed/29483783
      OpenUrlPubMed
    14. ↵
      1. Grissa MH,
      2. Baccouche H,
      3. Boubaker H, et al
      . Acupuncture vs intravenous morphine in the management of acute pain in the ED. Am J Emerg Med 2016;34:2112–6.doi:10.1016/j.ajem.2016.07.028pmid:http://www.ncbi.nlm.nih.gov/pubmed/27475042
      OpenUrlPubMed
    15. ↵
      1. Kaynar M,
      2. Koyuncu F,
      3. Buldu İbrahim, et al
      . Comparison of the efficacy of diclofenac, acupuncture, and acetaminophen in the treatment of renal colic. Am J Emerg Med 2015;33:749–53.doi:10.1016/j.ajem.2015.02.033pmid:http://www.ncbi.nlm.nih.gov/pubmed/25827597
      OpenUrlPubMed
    16. ↵
      1. Pei L,
      2. Geng H,
      3. Guo J, et al
      . Effect of acupuncture in patients with irritable bowel syndrome: a randomized controlled trial. Mayo Clin Proc 2020;95:1671–83.doi:10.1016/j.mayocp.2020.01.042pmid:http://www.ncbi.nlm.nih.gov/pubmed/32499125
      OpenUrlPubMed
    17. ↵
      1. Zhao L,
      2. Li D,
      3. Zheng H, et al
      . Acupuncture as adjunctive therapy for chronic stable angina: a randomized clinical trial. JAMA Intern Med 2019;179:1388–97.doi:10.1001/jamainternmed.2019.2407pmid:http://www.ncbi.nlm.nih.gov/pubmed/31355870
      OpenUrlPubMed
    18. ↵
      1. Jiang HF,
      2. Zhao C,
      3. Tang XF
      . Clinical analgesic effect of acupuncture at GB34 (Yanglingquan) and EX-LE6 (Dannang) for biliary colic caused by acute cholecystitis. J Hepatopancreatobiliary Surg 2016;28:481–3.
      OpenUrl
    19. ↵
      1. Cao ZY,
      2. Zhang YB,
      3. Zhang HC
      . Effects of electroacupuncturing at Yanglingquan on volume and arterial hemodynamics of gallbladder in chronic cholecystitis. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2016;22:1228–31.
      OpenUrl
    20. ↵
      1. Chen WH,
      2. HW Y
      . Puncturing on Yanglingquan point for relieving of colic pain of bile cyst. Acupunct Res 2000;01:62–3.
      OpenUrl
    21. ↵
      1. CB L,
      2. Zhu JM,
      3. Huang JP
      . Pain-Relieving effects of acupuncture at Yanglingquan and Dannang acupoints in acute cholecystitis. Shanghai Journal of Traditional Chinese Medicine 2011;45:56–7.
      OpenUrl
    22. ↵
      1. Kim MH
      . A brief commentary: electroacupuncture may relax the contraction of sphincter of Oddi. J Altern Complement Med 2001;7 Suppl 1:119–20.doi:10.1089/107555301753393887pmid:http://www.ncbi.nlm.nih.gov/pubmed/11822626
      OpenUrlPubMed
    23. ↵
      1. Lee SK,
      2. Kim MH,
      3. Kim HJ, et al
      . Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc 2001;53:211–6.doi:10.1067/mge.2001.112180pmid:http://www.ncbi.nlm.nih.gov/pubmed/11174298
      OpenUrlCrossRefPubMed
    24. ↵
      1. Zhao J,
      2. Yu Y,
      3. Luo M, et al
      . Bi-Directional regulation of acupuncture on extrahepatic biliary system: an approach in guinea pigs. Sci Rep 2017;7:14066. doi:10.1038/s41598-017-14482-xpmid:http://www.ncbi.nlm.nih.gov/pubmed/29070912
      OpenUrlPubMed
    25. ↵
      1. Ma C,
      2. Yang W
      . [The preventing and treating effects of electro-acupuncture on cholelithiasis in golden hamster]. Zhen Ci Yan Jiu 1996;21:68–72.pmid:http://www.ncbi.nlm.nih.gov/pubmed/9388323
      OpenUrlPubMed
    26. ↵
      1. Catani M,
      2. Dell'acqua F,
      3. Thiebaut de Schotten M
      . A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev 2013;37:1724–37.doi:10.1016/j.neubiorev.2013.07.001pmid:http://www.ncbi.nlm.nih.gov/pubmed/23850593
      OpenUrlCrossRefPubMed
    27. ↵
      1. Zhang F,
      2. Wu L,
      3. Zhao J, et al
      . Neurobiological mechanism of acupuncture for relieving visceral pain of gastrointestinal origin. Gastroenterol Res Pract 2017;2017:5687496 doi:10.1155/2017/5687496pmid:http://www.ncbi.nlm.nih.gov/pubmed/28243252
      OpenUrlPubMed
    28. ↵
      1. Liang C,
      2. Wang K,
      3. Xu B, et al
      . Electroacupuncture at acupoint ST 37(Shangjuxu) improves function of the enteric nervous system in a novel mouse constipation model. BMC Complement Altern Med 2016;16:392. doi:10.1186/s12906-016-1377-5pmid:http://www.ncbi.nlm.nih.gov/pubmed/27756367
      OpenUrlPubMed
    29. ↵
      1. Lu W,
      2. Dong K,
      3. Cui D, et al
      . Quality assurance of human functional magnetic resonance imaging: a literature review. Quant Imaging Med Surg 2019;9:1147–62.doi:10.21037/qims.2019.04.18pmid:http://www.ncbi.nlm.nih.gov/pubmed/31367569
      OpenUrlPubMed
    30. ↵
      1. Naseer N,
      2. Hong K-S
      . fNIRS-based brain-computer interfaces: a review. Front Hum Neurosci 2015;9:3. doi:10.3389/fnhum.2015.00003pmid:http://www.ncbi.nlm.nih.gov/pubmed/25674060
      OpenUrlPubMed
    31. ↵
      1. Huppert TJ,
      2. Diamond SG,
      3. Franceschini MA, et al
      . Homer: a review of time-series analysis methods for near-infrared spectroscopy of the brain. Appl Opt 2009;48:D280–98.doi:10.1364/AO.48.00D280pmid:http://www.ncbi.nlm.nih.gov/pubmed/19340120
      OpenUrlCrossRefPubMedWeb of Science
    32. ↵
      1. Fernandez Rojas R,
      2. Huang X,
      3. Ou K-L
      . Toward a functional near-infrared spectroscopy-based monitoring of pain assessment for nonverbal patients. J Biomed Opt 2017;22:1–12.doi:10.1117/1.JBO.22.10.106013pmid:http://www.ncbi.nlm.nih.gov/pubmed/29076307
      OpenUrlCrossRefPubMed
    33. ↵
      1. Gu Y,
      2. Miao S,
      3. Han J, et al
      . Complexity analysis of fNIRS signals in ADHD children during working memory task. Sci Rep 2017;7:829. doi:10.1038/s41598-017-00965-4pmid:http://www.ncbi.nlm.nih.gov/pubmed/28400568
      OpenUrlPubMed
    34. ↵
      1. Sukal-Moulton T,
      2. de Campos AC,
      3. Alter KE, et al
      . Relationship between sensorimotor cortical activation as assessed by functional near infrared spectroscopy and lower extremity motor coordination in bilateral cerebral palsy. Neuroimage Clin 2018;20:275–85.doi:10.1016/j.nicl.2018.07.023pmid:http://www.ncbi.nlm.nih.gov/pubmed/30101059
      OpenUrlPubMed
    35. ↵
      1. Yoon JA,
      2. Kong IJ,
      3. Choi J, et al
      . Neural compensatory response during complex cognitive function tasks in mild cognitive impairment: a near-infrared spectroscopy study. Neural Plast 2019;2019:7845104 doi:10.1155/2019/7845104pmid:http://www.ncbi.nlm.nih.gov/pubmed/31320893
      OpenUrlPubMed
    36. ↵
      1. Chan A-W,
      2. Tetzlaff JM,
      3. Gøtzsche PC, et al
      . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586. doi:10.1136/bmj.e7586pmid:http://www.ncbi.nlm.nih.gov/pubmed/23303884
      OpenUrlAbstract/FREE Full Text
    37. ↵
      1. Schulz KF,
      2. Altman DG,
      3. Moher D, et al
      . Consort 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. doi:10.1136/bmj.c332pmid:http://www.ncbi.nlm.nih.gov/pubmed/20332509
      OpenUrlFREE Full Text
    38. ↵
      1. MacPherson H,
      2. Altman DG,
      3. Hammerschlag R, et al
      . Revised standards for reporting interventions in clinical trials of acupuncture (stricta): extending the CONSORT statement. PLoS Med 2010;7:e1000261. doi:10.1371/journal.pmed.1000261pmid:http://www.ncbi.nlm.nih.gov/pubmed/20543992
      OpenUrlCrossRefPubMed
    39. ↵
      1. European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu
      . EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016;65:146–81.doi:10.1016/j.jhep.2016.03.005pmid:http://www.ncbi.nlm.nih.gov/pubmed/27085810
      OpenUrlCrossRefPubMed
    40. ↵
      1. Zung WW
      . A rating instrument for anxiety disorders. Psychosomatics 1971;12:371–9.doi:10.1016/S0033-3182(71)71479-0pmid:http://www.ncbi.nlm.nih.gov/pubmed/5172928
      OpenUrlCrossRefPubMedWeb of Science
    41. ↵
      1. Zung WW
      . A self-rating depression scale. Arch Gen Psychiatry 1965;12:63–70.doi:10.1001/archpsyc.1965.01720310065008pmid:http://www.ncbi.nlm.nih.gov/pubmed/14221692
      OpenUrlCrossRefPubMedWeb of Science
    42. ↵
      1. Wang L-P,
      2. Zhang X-Z,
      3. Guo J, et al
      . Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled trial. Pain Med 2012;13:623–30.doi:10.1111/j.1526-4637.2012.01376.xpmid:http://www.ncbi.nlm.nih.gov/pubmed/22536889
      OpenUrlPubMed
    43. ↵
      1. Friston K
      . Ten ironic rules for non-statistical reviewers. Neuroimage 2012;61:1300–10.doi:10.1016/j.neuroimage.2012.04.018pmid:http://www.ncbi.nlm.nih.gov/pubmed/22521475
      OpenUrlCrossRefPubMedWeb of Science
    44. ↵
      1. Dhond RP,
      2. Yeh C,
      3. Park K, et al
      . Acupuncture modulates resting state connectivity in default and sensorimotor brain networks. Pain 2008;136:407–18.doi:10.1016/j.pain.2008.01.011pmid:http://www.ncbi.nlm.nih.gov/pubmed/18337009
      OpenUrlCrossRefPubMedWeb of Science
    45. ↵
      1. Zeng F,
      2. Qin W,
      3. Ma T, et al
      . Influence of acupuncture treatment on cerebral activity in functional dyspepsia patients and its relationship with efficacy. Am J Gastroenterol 2012;107:1236–47.doi:10.1038/ajg.2012.53pmid:http://www.ncbi.nlm.nih.gov/pubmed/22641307
      OpenUrlCrossRefPubMed
    46. ↵
      1. Yin T,
      2. He Z,
      3. Ma P, et al
      . Effect and cerebral mechanism of acupuncture treatment for functional constipation: study protocol for a randomized controlled clinical trial. Trials 2019;20:283. doi:10.1186/s13063-019-3410-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/31126315
      OpenUrlPubMed
    47. ↵
      1. Sun R,
      2. Hong X,
      3. Guo J, et al
      . The central mechanism of acupuncture treatment with a long-lasting effect for functional dyspepsia: study protocol for a randomized controlled trial. Trials 2018;19:373. doi:10.1186/s13063-018-2742-0pmid:http://www.ncbi.nlm.nih.gov/pubmed/30001732
      OpenUrlPubMed
    48. ↵
      1. Park J,
      2. White A,
      3. Stevinson C, et al
      . Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Acupunct Med 2002;20:168–74.doi:10.1136/aim.20.4.168pmid:http://www.ncbi.nlm.nih.gov/pubmed/12512790
      OpenUrlPubMed
    49. ↵
      1. Lund I,
      2. Lundeberg T
      . Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med 2006;24:13–15.doi:10.1136/aim.24.1.13
      OpenUrlPubMed
    50. ↵
      1. Farrar JT,
      2. Young JP,
      3. LaMoreaux L, et al
      . Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149–58.doi:10.1016/S0304-3959(01)00349-9pmid:http://www.ncbi.nlm.nih.gov/pubmed/11690728
      OpenUrlCrossRefPubMedWeb of Science
    51. ↵
      1. Ferreira-Valente MA,
      2. Pais-Ribeiro JL,
      3. Jensen MP
      . Validity of four pain intensity rating scales. Pain 2011;152:2399–404.doi:10.1016/j.pain.2011.07.005pmid:http://www.ncbi.nlm.nih.gov/pubmed/21856077
      OpenUrlCrossRefPubMedWeb of Science
    52. ↵
      1. Ware J,
      2. Kosinski M,
      3. Keller SD
      . A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.doi:10.1097/00005650-199603000-00003pmid:http://www.ncbi.nlm.nih.gov/pubmed/8628042
      OpenUrlCrossRefPubMedWeb of Science
    53. ↵
      1. Kong J,
      2. Gollub R,
      3. Huang T, et al
      . Acupuncture de Qi, from qualitative history to quantitative measurement. J Altern Complement Med 2007;13:1059–70.doi:10.1089/acm.2007.0524pmid:http://www.ncbi.nlm.nih.gov/pubmed/18166116
      OpenUrlCrossRefPubMedWeb of Science
    54. ↵
      1. Yu DTW,
      2. Jones AYM,
      3. Pang MYC
      . Development and validation of the Chinese version of the Massachusetts General Hospital acupuncture sensation scale: an exploratory and methodological study. Acupunct Med 2012;30:214–21.doi:10.1136/acupmed-2012-010145pmid:http://www.ncbi.nlm.nih.gov/pubmed/22617434
      OpenUrlCrossRefPubMed
    55. ↵
      1. Yuan H-W,
      2. Ma L-X,
      3. Qi D-D, et al
      . The historical development of deqi concept from classics of traditional Chinese medicine to modern research: exploitation of the connotation of deqi in Chinese medicine. Evid Based Complement Alternat Med 2013;2013:1–5.doi:10.1155/2013/639302pmid:http://www.ncbi.nlm.nih.gov/pubmed/24302968
      OpenUrlCrossRefPubMed
    56. ↵
      1. Chen Y,
      2. Yao Y,
      3. Wu Y, et al
      . Transcutaneous electric acupoint stimulation alleviates remifentanil-induced hyperalgesia in patients undergoing thyroidectomy: a randomized controlled trial. Int J Clin Exp Med 2015;8:5781–7.pmid:http://www.ncbi.nlm.nih.gov/pubmed/26131165
      OpenUrlPubMed
    57. ↵
      1. Neto MLP,
      2. Maciel LYS,
      3. Cruz KML, et al
      . Does electrode placement influence tens-induced antihyperalgesia in experimental inflammatory pain model? Braz J Phys Ther 2017;21:92–9.doi:10.1016/j.bjpt.2017.03.003pmid:http://www.ncbi.nlm.nih.gov/pubmed/28460716
      OpenUrlPubMed
    58. ↵
      1. Yamamoto S,
      2. Ono H,
      3. Kume K, et al
      . Oxaliplatin treatment changes the function of sensory nerves in rats. J Pharmacol Sci 2016;130:189–93.doi:10.1016/j.jphs.2015.12.004pmid:http://www.ncbi.nlm.nih.gov/pubmed/26790975
      OpenUrlPubMed
    59. ↵
      1. Persson AL,
      2. Brogårdh C,
      3. Sjölund BH
      . Tender or not tender: test-retest repeatability of pressure pain thresholds in the trapezius and deltoid muscles of healthy women. J Rehabil Med 2004;36:17–27.doi:10.1080/16501970310015218pmid:http://www.ncbi.nlm.nih.gov/pubmed/15074434
      OpenUrlCrossRefPubMedWeb of Science
    60. ↵
      1. Fischer AA
      . Pressure algometry over normal muscles. standard values, validity and reproducibility of pressure threshold. Pain 1987;30:115–26.doi:10.1016/0304-3959(87)90089-3pmid:http://www.ncbi.nlm.nih.gov/pubmed/3614975
      OpenUrlCrossRefPubMedWeb of Science
    61. ↵
      1. Sun M,
      2. Tao S,
      3. Geng G, et al
      . Identification of the optimal points for the acupuncture treatment of neck pain in China: protocol for a multicenter, matched, case-control study. BMJ Open 2019;9:e029194. doi:10.1136/bmjopen-2019-029194pmid:http://www.ncbi.nlm.nih.gov/pubmed/31439605
      OpenUrlAbstract/FREE Full Text
    62. ↵
      1. Scholkmann F,
      2. Kleiser S,
      3. Metz AJ, et al
      . A review on continuous wave functional near-infrared spectroscopy and imaging instrumentation and methodology. Neuroimage 2014;85 Pt 1:6–27.doi:10.1016/j.neuroimage.2013.05.004pmid:http://www.ncbi.nlm.nih.gov/pubmed/23684868
      OpenUrlCrossRefPubMed
    63. ↵
      1. Okamoto M,
      2. Dan H,
      3. Sakamoto K, et al
      . Three-Dimensional probabilistic anatomical cranio-cerebral correlation via the International 10-20 system oriented for transcranial functional brain mapping. Neuroimage 2004;21:99–111.doi:10.1016/j.neuroimage.2003.08.026pmid:http://www.ncbi.nlm.nih.gov/pubmed/14741647
      OpenUrlCrossRefPubMedWeb of Science
    64. ↵
      1. Tsuzuki D,
      2. Cai D-sheng,
      3. Dan H, et al
      . Stable and convenient spatial registration of stand-alone NIRS data through anchor-based probabilistic registration. Neurosci Res 2012;72:163–71.doi:10.1016/j.neures.2011.10.008pmid:http://www.ncbi.nlm.nih.gov/pubmed/22062377
      OpenUrlCrossRefPubMed
    65. ↵
      1. Gratton G,
      2. Brumback CR,
      3. Gordon BA, et al
      . Effects of measurement method, wavelength, and source-detector distance on the fast optical signal. Neuroimage 2006;32:1576–90.doi:10.1016/j.neuroimage.2006.05.030pmid:http://www.ncbi.nlm.nih.gov/pubmed/16872842
      OpenUrlCrossRefPubMedWeb of Science
    66. ↵
      1. Molavi B,
      2. Dumont GA
      . Wavelet-based motion artifact removal for functional near-infrared spectroscopy. Physiol Meas 2012;33:259–70.doi:10.1088/0967-3334/33/2/259pmid:http://www.ncbi.nlm.nih.gov/pubmed/22273765
      OpenUrlCrossRefPubMed
    67. ↵
      1. Wyatt JS,
      2. Cope M,
      3. Delpy DT, et al
      . Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry. Lancet 1986;2:1063–6.doi:10.1016/S0140-6736(86)90467-8pmid:http://www.ncbi.nlm.nih.gov/pubmed/2877225
      OpenUrlCrossRefPubMedWeb of Science
    68. ↵
      1. Strangman G,
      2. Culver JP,
      3. Thompson JH, et al
      . A quantitative comparison of simultaneous BOLD fMRI and NIRS recordings during functional brain activation. Neuroimage 2002;17:719–31.doi:10.1006/nimg.2002.1227pmid:http://www.ncbi.nlm.nih.gov/pubmed/12377147
      OpenUrlCrossRefPubMedWeb of Science
    69. ↵
      1. Duan L,
      2. Zhao Z,
      3. Lin Y, et al
      . Wavelet-based method for removing global physiological noise in functional near-infrared spectroscopy. Biomed Opt Express 2018;9:3805–20.doi:10.1364/BOE.9.003805pmid:http://www.ncbi.nlm.nih.gov/pubmed/30338157
      OpenUrlPubMed
    70. ↵
      1. Linde K,
      2. Niemann K,
      3. Schneider A, et al
      . How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Med 2010;8:75. doi:10.1186/1741-7015-8-75pmid:http://www.ncbi.nlm.nih.gov/pubmed/21092261
      OpenUrlCrossRefPubMed
    71. ↵
      1. Birch S
      . A review and analysis of placebo treatments, placebo effects, and placebo controls in trials of medical procedures when sham is not inert. J Altern Complement Med 2006;12:303–10.doi:10.1089/acm.2006.12.303pmid:http://www.ncbi.nlm.nih.gov/pubmed/16646730
      OpenUrlCrossRefPubMedWeb of Science
    72. ↵
      1. MacPherson H,
      2. Vertosick E,
      3. Lewith G, et al
      . Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis. PLoS One 2014;9:e93739. doi:10.1371/journal.pone.0093739pmid:http://www.ncbi.nlm.nih.gov/pubmed/24705624
      OpenUrlCrossRefPubMed
    73. ↵
      1. Xu S,
      2. Yu L,
      3. Luo X, et al
      . Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ 2020;368:m697.doi:10.1136/bmj.m697pmid:http://www.ncbi.nlm.nih.gov/pubmed/32213509
      OpenUrlAbstract/FREE Full Text
    74. ↵
      1. Ots T,
      2. Kandirian A,
      3. Szilagyi I, et al
      . The selection of dermatomes for sham (placebo) acupuncture points is relevant for the outcome of acupuncture studies: a systematic review of sham (placebo)-controlled randomized acupuncture trials. Acupunct Med 2020;38:211–26.doi:10.1177/0964528419889636pmid:http://www.ncbi.nlm.nih.gov/pubmed/32026725
      OpenUrlPubMed
    75. ↵
      1. Xiao QW,
      2. Li J,
      3. Ye J
      . Research on the phenomenon and regularity of acupoint sensitization forcervical spondylosis. China Journal of Traditional Chinese Medicine and Pharmacy 2020;35:89–92.
      OpenUrl
    76. ↵
      1. Ye J,
      2. Yang H,
      3. Xiao QW
      . Phenomenon and regularity of acupoints sensitization for knee osteoarthritis. China Journal of Traditional Chinese Medicine and Pharmacy 2019;34:5127–30.
      OpenUrl
    77. ↵
      1. Wang X,
      2. Li J,
      3. Ye J
      . Study on acupoint sensitization of lumbar BI disease and its regularity. Lishizhen Medicine and Materia Medica Research 2018;29:1483–6.
      OpenUrl
    78. ↵
      1. Ferrari M,
      2. Quaresima V
      . A brief review on the history of human functional near-infrared spectroscopy (fNIRS) development and fields of application. Neuroimage 2012;63:921–35.doi:10.1016/j.neuroimage.2012.03.049pmid:http://www.ncbi.nlm.nih.gov/pubmed/22510258
      OpenUrlCrossRefPubMedWeb of Science
    79. ↵
      1. Pinti P,
      2. Tachtsidis I,
      3. Hamilton A, et al
      . The present and future use of functional near-infrared spectroscopy (fNIRS) for cognitive neuroscience. Ann N Y Acad Sci 2020;1464:5–29.doi:10.1111/nyas.13948pmid:http://www.ncbi.nlm.nih.gov/pubmed/30085354
      OpenUrlCrossRefPubMed
    80. ↵
      1. Lloyd-Fox S,
      2. Blasi A,
      3. Elwell CE
      . Illuminating the developing brain: the past, present and future of functional near infrared spectroscopy. Neurosci Biobehav Rev 2010;34:269–84.doi:10.1016/j.neubiorev.2009.07.008pmid:http://www.ncbi.nlm.nih.gov/pubmed/19632270
      OpenUrlCrossRefPubMedWeb of Science
    81. ↵
      1. Jeun S-S,
      2. Kim J-S,
      3. Kim B-S, et al
      . Acupuncture stimulation for motor cortex activities: a 3T fMRI study. Am J Chin Med 2005;33:573–8.doi:10.1142/S0192415X0500317Xpmid:http://www.ncbi.nlm.nih.gov/pubmed/16173531
      OpenUrlCrossRefPubMed
    82. ↵
      1. Maeda Y,
      2. Kim H,
      3. Kettner N, et al
      . Rewiring the primary somatosensory cortex in carpal tunnel syndrome with acupuncture. Brain 2017;140:914–27.doi:10.1093/brain/awx015pmid:http://www.ncbi.nlm.nih.gov/pubmed/28334999
      OpenUrlPubMed
    83. ↵
      1. Liu J,
      2. Chen L,
      3. Tu Y, et al
      . Different exercise modalities relieve pain syndrome in patients with knee osteoarthritis and modulate the dorsolateral prefrontal cortex: a multiple mode MRI study. Brain Behav Immun 2019;82:253–63.doi:10.1016/j.bbi.2019.08.193pmid:http://www.ncbi.nlm.nih.gov/pubmed/31472246
      OpenUrlPubMed
    84. ↵
      1. Seminowicz DA,
      2. Moayedi M
      . The dorsolateral prefrontal cortex in acute and chronic pain. J Pain 2017;18:1027–35.doi:10.1016/j.jpain.2017.03.008pmid:http://www.ncbi.nlm.nih.gov/pubmed/28400293
      OpenUrlCrossRefPubMed
    85. ↵
      1. Lorenz J,
      2. Minoshima S,
      3. Casey KL
      . Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003;126:1079–91.doi:10.1093/brain/awg102pmid:http://www.ncbi.nlm.nih.gov/pubmed/12690048
      OpenUrlCrossRefPubMedWeb of Science
    86. ↵
      1. Freund W,
      2. Klug R,
      3. Weber F, et al
      . Perception and suppression of thermally induced pain: a fMRI study. Somatosens Mot Res 2009;26:1–10.doi:10.1080/08990220902738243pmid:http://www.ncbi.nlm.nih.gov/pubmed/19283551
      OpenUrlCrossRefPubMed

    Footnotes

    • Contributors RS, F-rL and NS participated in the conception and design of the trial. NS, D-MH and XY participated in drafting the manuscript. LB, XD, YZ, T-HZ and SS will be responsible for participants recruitment. NS and YZ will perform the acupuncture for participants. ZL, SC and JC will be in charge of data collection. NS, RS and F-JZ will conduct data analysis. All authors discussed, read, revised the manuscript and all approved the publication of this protocol.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.